How useful has anti-aggregation therapy proven to be today?
Francetić, I.
Lijecnicki Vjesnik 105(7-8): 323-324
1983
ISSN/ISBN: 0024-3477 PMID: 6633156 Document Number: 202241
Document emailed within 1 workday
Related Documents
Uzelac, S.; Modrić, B. 1989: Anti-aggregation therapy. Mechanism of its effect and evaluation of its preventive value Vojnosanitetski Pregled 46(2): 119-123Zarranz Imirizaldu, J.J. 1997: Anti-aggregation therapy for prevention of cerebral ischemic stroke: a risk benefit analysis Medicina Clinica 109(20): 802-807
Eber, B.; Klein, W.; Fluch, N.; Dusleag, J.; Weinrauch, V.; Rotman, B.; Gasser, R.; Kronberger-Schaffer, E. 1989: Do thrombocyte aggregation inhibitors modify silent episodes of unstable angina pectoris in combined anti-angina therapy? Zeitschrift für Kardiologie 78(Suppl 2): 150-154; Discussion 159
Williams, R.C.; Malone, C.C.; Casali, P. 1992: Heteroclitic polyclonal and monoclonal anti-Gm(a) and anti-Gm(g) human rheumatoid factors react with epitopes induced in Gm(a-), Gm(g-) IgG by interaction with antigen or by nonspecific aggregation. a possible mechanism for the in vivo generation of rheumatoid factors Journal of Immunology 149(5): 1817-1824
Murina, M.A.; Kuznetsov, V.N.; Roshchupkin, D.I. 1986: Anti-aggregation action of hypochlorite on the thrombocytes Biulleten' Eksperimental'noi Biologii i Meditsiny 102(12): 676-678
Chiariello, M.; Piacenza, G.; Pesce, E. 1978: In vitro anti-aggregation activity of Ozopulmin Bollettino Chimico Farmaceutico 117(9): 549-552
Mauro, R.; Calatola, P.; Di Donato, F.; Frey, L.; Lettieri, A. 1978: Anti-platelet-aggregation drugs and atherosclerosis Minerva Medica 69(33): 2285-2288
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Berisso, M.Z.; Canonero, D.; Caruso, D.; Setti, S.; Domenicucci, S. 2010: Cardiac resynchronization therapy with defibrillation capability: considerations on a not yet proven therapeutic superiority Giornale Italiano di Cardiologia 11(4): 295-305
Duschet, P.; Schwarz, T.; Gschnait, F. 1989: Plasmapheresis in light urticaria. a rational therapy concept in cases with a proven serum factor Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 40(9): 553-555
Gofferje, H. 1976: Infusion therapy today. 2. Disorders of sodium and water balance. Pathophysiology, diagnosis and therapy Die Medizinische Welt 27(18): 879-883
Gorin, N.C.; Fraitag, B.; Feldman, A.; Vallot, T.; Couturier, J.Y.; Najman, A.; Duhamel, G. 1977: Moschowitz's disease: efficacy of anti-platelet aggregation agents La Nouvelle Presse Medicale 6(42): 3959-3961
Takano, S.; Aikawa, T.; Oishi, T.; Goto, M.; Tamura, O.; Suzuki, T. 1979: Effects of anti-inflammatory drugs on platelet aggregation in rabbits Research Communications in Chemical Pathology and Pharmacology 24(3): 501-514
Gonzalez-Juanatey, C.; Llorca, J.; Garcia-Porrua, C.; Sanchez-Andrade, A.; Martín, J.; Gonzalez-Gay, M.A. 2006: Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis Journal of Rheumatology 33(1): 74-78
Bicher, H.I. 1970: Anti-thrombotic effect of an heparin-like substance (SP 54) preventing red cell and platelet aggregation Arzneimittel-Forschung 20(3): 379-381
Kurbanov, R.D.; Azimova, N.A.; Kiakbaev, G.K.; Abdullaev, T.A.; Asriiants, L.S.; Zakirov, N.U.; Avezov, D.K.; Faĭzullaev, B.P. 1993: Thrombocyte aggregation in patients with cardiac arrhythmias and effect of anti-arrhythmia agents Kardiologiia 33(5): 27-29
Yang, Y.; Zuo, J.; Li, J.-m.; Ma, X.-d.; Zhang, Y.-c.; Huang, W.-j. 2017: Design, synthesis, and biological evaluation of phenylpropenamides compounds as anti-platelet aggregation Yao Xue Xue Bao 52(1): 120-125
Marrakchi, N.; Guermazi, S.; El Ayeb, M. 1997: The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides Archives de l'Institut Pasteur de Tunis 74(1-2): 9-15
Arjona, A.; Bartolomé, M.T.; Mata, M.; Corral, F.; Blasco, M.R.; Jiménez, C. 1997: Idiopathic multiple cerebral hemorrhage: are platelet anti-aggregation agents a risk factor? Revista de Neurologia 25(148): 2069
Busygina, O.G.; Belushkina, N.N.; Grigor'ev, N.B.; Severina, I.S. 1995: A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties Biokhimiia 60(9): 1460-1467